Literature DB >> 4032046

Technetium-99m low density lipoproteins: preparation and biodistribution.

R S Lees, H D Garabedian, A M Lees, D J Schumacher, A Miller, J L Isaacsohn, A Derksen, H W Strauss.   

Abstract

The focal uptake by human atherosclerotic lesions of 125I bound to low density lipoproteins (LDL) can be demonstrated by external imaging. However, 125I has poor imaging characteristics. Therefore, we have developed a technique for labeling LDL with technetium. To facilitate analysis, LDL was first labeled with 99mTc, by reduction of TcO4- with dithionite in the presence of the protein. The labeled LDL was stable to electrophoresis, ultracentrifugation, and passage in vivo. This technique was repeated with minor modification with 99mTc to prepare [99mTc] LDL for use as an imaging agent. Its biodistribution in 16 rabbits was similar to that of [125I] LDL and it allowed high resolution external imaging of LDL uptake by tissues, including the injured, healing, arterial wall, and the adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4032046

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Recombinant antibody-metallothionein: design and evaluation for radioimmunoimaging.

Authors:  C Das; P V Kulkarni; A Constantinescu; P Antich; F R Blattner; P W Tucker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 2.  Nuclear medicine and atherosclerosis.

Authors:  H Sinzinger; I Virgolini
Journal:  Eur J Nucl Med       Date:  1990

Review 3.  Molecular imaging will replace perfusion imaging: The impossible dream.

Authors:  E Gordon Depuey
Journal:  J Nucl Cardiol       Date:  2008 May-Jun       Impact factor: 5.952

4.  The visualization of femoral vessels in delayed bone scans--a sign of arteriosclerosis? A comparison of 99mTc-MDP and 99mTc-DPD.

Authors:  T Lantto; K Järvi; I Toivio; S Vähätalo; M Vorne
Journal:  Eur J Nucl Med       Date:  1989

5.  Low density lipoprotein receptor-independent hepatic uptake of a synthetic, cholesterol-scavenging lipoprotein: implications for the treatment of receptor-deficient atherosclerosis.

Authors:  K J Williams; S Vallabhajosula; I U Rahman; T M Donnelly; T S Parker; M Weinrauch; S J Goldsmith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  Radiolabeled cholesteryl iopanoate/acetylated low density lipoprotein as a potential probe for visualization of early atherosclerotic lesions in rabbits.

Authors:  W Xiao; L Wang; T Scott; R E Counsell; H Liu
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

7.  Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. I. Tracer purification, in vitro and in vivo long-term stability, in vitro validation and biodistribution.

Authors:  T Leitha; M Hermann; M Hüttinger; P Angelberger; R Dudczak
Journal:  Eur J Nucl Med       Date:  1993-08

8.  Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. II. In vivo validation, LDL receptor-dependent and unspecific hepatic uptake and scintigraphic results.

Authors:  T Leitha; A Staudenherz; B Gmeiner; M Hermann; M Hüttinger; R Dudczak
Journal:  Eur J Nucl Med       Date:  1993-08

9.  Preparation and investigation of 99m technetium-labeled low-density lipoproteins in rabbits with experimentally induced hypercholesterolemia.

Authors:  Z Bozóky; L Balogh; D Máthé; L Fülöp; L Bertók; Gy A Jánoki
Journal:  Eur Biophys J       Date:  2003-12-09       Impact factor: 1.733

Review 10.  Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview.

Authors:  L M Riou; A Broisat; J Dimastromatteo; G Pons; D Fagret; C Ghezzi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.